
Episode 203 - November 13, 2026
AI summary Biotech market sentiment remains cautious, with investors shifting capital toward large-cap, commercial-stage companies while avoiding binary, development-stage risks. Despite leadership uncertainty, the FDA maintains high functionality, tracking toward a record year for new…
- FDA (Food and Drug Administration)
- PDUFA (Prescription Drug User Fee Act)
- KOL (Key Opinion Leader)
01:01:04EnglishSummary · Transcript


















